Vascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises

B Descamps, C Emanueli

Research output: Contribution to journalArticle (Academic Journal)

28 Citations (Scopus)

Abstract

Stem cell (SC) therapy represents a big hope for treating unmet clinical needs, including in the context of cardiovascular disease. The abilities of embryonic SC (ESCs) to self-renew indefinitely and to differentiate in all the three germ layers make these SCs very attractive for both basic science investigations and clinical therapies. ESCs can generate vascular endothelial and mural cells to be used for transplantation and to create engineered organs. Moreover ESC can be used to mimic developmental vasculogenesis and angiogenesis in vitro. However, additional studies are needed to improve vascular differentiation protocols of ESCs. This review focuses on ESCs and the technologies allowing for their differentiation into mesoderm and vascular lineage. Moreover, the potential of ESC-derived vascular cells for clinical cardiovascular therapies and strategies to improve ESC engraftment efficiency are discussed.
Translated title of the contributionVascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises
Original languageEnglish
Pages (from-to)267 - 279
Number of pages13
JournalVascular Pharmacology
Volume56(5-6)
DOIs
Publication statusPublished - May 2012

Fingerprint Dive into the research topics of 'Vascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises'. Together they form a unique fingerprint.

  • Cite this